WPRIM Management System> DCMS> Chinese Journal of Lung Cancer> 2023> 26> 9

Volume: 26 Issue: 9

1. A Novel Chinese Medicine Formula Inhibits Non-small Cell Lung Cancer by Triggering Oxidative Stress Dependent on Pentose Phosphate Pathway. Page:639—649
2. Analysis of Clinicopathological Features on Spread Through Air Spaces
of Lung Adenocarcinoma. Page:650—658
3. Evaluation of Efficacy and Prognosis Analysis of Stage III-IV SMARCA4-deficient 
Non-small Cell Lung Cancer Treated by PD-1 Immune Checkpoint Inhibitors plus 
Chemotherapy and Chemotherapy. Page:659—668
4. Identification of SULF1 as a Shared Gene in Idiopathic Pulmonary Fibrosis
and Lung Adenocarcinoma. Page:669—683
5. Drug Resistance Mechanism and Therapeutic Strategy of Targeted Therapy of 
Non-small Cell Lung Cancer with MET Alterations. Page:684—691
6. Research Progress of Lung Cancer Vaccines. Page:692—700
7. Research Advances of RAD51AP1 in Tumor Progression and Drug Resistance. Page:701—708
8. Immune Checkpoint Inhibitors Related Cystoureteritis:
A Case Report and Literature Review. Page:709—716
9. Immune Thrombocytopenia Induced by Sintilimab in Lung Cancer: 
A Case Report and Literature Review. Page:717—720

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.